SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Triochem Products - Quaterly Results

04 Nov 2023 Evaluate
A slight decline in the revenue of Rs. 0.00 millions was seen for the September 2023 quarter as against Rs. 0.00 millions during year-ago period.The Net Loss for the quarter ended September 2023 is Rs. -10.26 millions as compared to Net Loss of Rs. -2.45 millions of corresponding quarter ended September 2022 Operating profit Margin for the quarter ended September 2023 further decreased to -2.40% as compared to -2.93% of corresponding quarter ended September 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 88.22 0.00
Other Income 0.55 0.70 -21.43 1.92 1.75 9.71 2.78 5.65 -50.80
PBIDT -2.40 -2.93 -18.09 -3.61 -5.24 -31.11 -10.65 18.99 -156.08
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.17 -100.00
PBDT -13.97 -2.93 376.79 -15.18 -5.24 189.69 -10.65 18.82 -156.59
Depreciation 0.23 0.26 -11.54 0.45 0.52 -13.46 1.05 1.19 -11.76
PBT -14.20 -3.19 345.14 -15.63 -5.76 171.35 -11.70 17.63 -166.36
TAX -3.94 -0.74 432.43 -4.29 -1.38 210.87 -2.85 4.40 -164.77
Deferred Tax -3.94 -0.65 506.15 -4.29 -1.29 232.56 -2.76 1.06 -360.38
PAT -10.26 -2.45 318.78 -11.34 -4.38 158.90 -8.85 13.23 -166.89
Equity 2.45 2.45 0.00 2.45 2.45 0.00 2.45 2.45 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 21.53 0.00
Peers
Company Name CMP
Sun Pharma Inds. 1693.15
Dr. Reddys Lab 1221.25
Cipla 1230.75
Zydus Lifesciences 938.00
Lupin 2322.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×